These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 32404212

  • 1. Basic symptoms and gray matter volumes of patients at clinical high risk for psychosis.
    Hubl D, Michel C, Schultze-Lutter F, Hauf M, Schimmelmann BG, Kaess M, Kindler J.
    Psychol Med; 2021 Nov; 51(15):2666-2674. PubMed ID: 32404212
    [Abstract] [Full Text] [Related]

  • 2. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
    Pelizza L, Azzali S, Garlassi S, Paterlini F, Scazza I, Chiri LR, Pupo S, Raballo A.
    Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
    [Abstract] [Full Text] [Related]

  • 3. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C, Toffel E, Schmidt SJ, Eliez S, Armando M, Solida-Tozzi A, Schultze-Lutter F, Debbané M.
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [Abstract] [Full Text] [Related]

  • 4. Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up.
    Cropley VL, Lin A, Nelson B, Reniers RLEP, Yung AR, Bartholomeusz CF, Klauser P, Velakoulis D, McGorry P, Wood SJ, Pantelis C.
    Schizophr Res; 2016 Jun; 173(3):152-158. PubMed ID: 26032566
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N, Saba R, Hauser M, Vernal DL, Al-Jadiri A, Borenstein Y, Sheridan EM, Kishimoto T, Armando M, Vicari S, Fiori Nastro P, Girardi P, Gebhardt E, Kane JM, Auther A, Carrión RE, Cornblatt BA, Schimmelmann BG, Schultze-Lutter F, Correll CU.
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Does neuroanatomy account for superior temporal dysfunction in early psychosis? A multimodal MRI investigation.
    Pettersson-Yeo W, Benetti S, Frisciata S, Catani M, Williams SC, Allen P, McGuire P, Mechelli A.
    J Psychiatry Neurosci; 2015 Mar; 40(2):100-7. PubMed ID: 25338016
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.
    Bakker G, Caan MW, Vingerhoets WA, da Silva-Alves F, de Koning M, Boot E, Nieman DH, de Haan L, Bloemen OJ, Booij J, van Amelsvoort TA.
    PLoS One; 2016 Mar; 11(11):e0159928. PubMed ID: 27828960
    [Abstract] [Full Text] [Related]

  • 12. Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms.
    Schultze-Lutter F, Klosterkötter J, Ruhrmann S.
    Schizophr Res; 2014 Apr; 154(1-3):100-6. PubMed ID: 24613572
    [Abstract] [Full Text] [Related]

  • 13. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B, Kebir O, Mam-Lam-Fook C, Morvan Y, Bourgin J, Godsil BP, Plaze M, Gaillard R, Jay TM, Krebs MO.
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Investigation of structural brain correlates of neurological soft signs in individuals at ultra-high risk for psychosis.
    Wang Y, Braam EE, Wannan CMJ, Van Rheenen TE, Chan RCK, Nelson B, McGorry PD, Yung AR, Lin A, Brewer WJ, Koutsogiannis J, Wood SJ, Velakoulis D, Pantelis C, Cropley VL.
    Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1475-1485. PubMed ID: 34467451
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional and structural correlates of abnormal involuntary movements in psychosis risk and first episode psychosis.
    Kindler J, Michel C, Schultze-Lutter F, Felber G, Hauf M, Schimmelmann BG, Kaess M, Hubl D, Walther S.
    Schizophr Res; 2019 Oct; 212():196-203. PubMed ID: 31405623
    [Abstract] [Full Text] [Related]

  • 19. Non-reduction in hippocampal volume is associated with higher risk of psychosis.
    Phillips LJ, Velakoulis D, Pantelis C, Wood S, Yuen HP, Yung AR, Desmond P, Brewer W, McGorry PD.
    Schizophr Res; 2002 Dec 01; 58(2-3):145-58. PubMed ID: 12409154
    [Abstract] [Full Text] [Related]

  • 20. Localized gray matter volume reductions in the pars triangularis of the inferior frontal gyrus in individuals at clinical high-risk for psychosis and first episode for schizophrenia.
    Iwashiro N, Suga M, Takano Y, Inoue H, Natsubori T, Satomura Y, Koike S, Yahata N, Murakami M, Katsura M, Gonoi W, Sasaki H, Takao H, Abe O, Kasai K, Yamasue H.
    Schizophr Res; 2012 May 01; 137(1-3):124-31. PubMed ID: 22425035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.